{"title":"总编辑欢迎辞","authors":"Qiuwang Zhang","doi":"10.14740/CMMR.V1I1.17","DOIUrl":null,"url":null,"abstract":"I am greatly honored to be appointed as the inaugural Editor-inChief of Cellular and Molecular Medicine Research (CMMR), an international, open access, and peer-reviewed journal. The goals of this journal are to provide a new avenue for scientists and clinicians to publish their laboratory and clinical research findings, as well as to disseminate information, opinions, and knowledge in cellular and molecular medicine research. Cellular and molecular approaches are pivotal and have long been employed in medicine and clinical research. To cite a few instances, polymerase chain reaction (PCR), a molecular method developed over three decades ago, has been widely applied in disease diagnosis, disease mechanism deciphering, and prognosis prediction; the elucidation of tyrosine kinase activity in cancer cells has led to the development of novel drugs for cancer treatment; and the identification of proteins and genetic molecules by molecular methods as biomarkers for disease diagnosis and prognosis has been drawing great interest. We hope CMMR will serve as a vessel furthering cellular and molecular medicine research. We welcome submissions in the form of original research articles, reviews, short communications, etc. This journal comes into being at the time of an explosion in open access journals. With this recognition, we will make every effort to better meet the needs of authors as well as provide readers with high quality articles. Specifically, during the peer-review process, each submission will be reviewed by experts with relevant expertise, ensuring fair and objective decision-making, which will be guaranteed by experts sitting on the Editorial Board. Additionally, assistance in English editing will be offered to authors whose native language is not English. With hard work and full support from the Editorial Board and the editorial office, I believe the journal will attract submissions from scientists as well as clinicians in the field of cellular and molecular medicine research. I am privileged to have this opportunity to lead the journal and serve our prospective authors and readers, and am looking forward to your contributions and support.","PeriodicalId":407983,"journal":{"name":"Central European Journal of Engineering","volume":"106 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Welcome Message from the Editor-in-Chief\",\"authors\":\"Qiuwang Zhang\",\"doi\":\"10.14740/CMMR.V1I1.17\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"I am greatly honored to be appointed as the inaugural Editor-inChief of Cellular and Molecular Medicine Research (CMMR), an international, open access, and peer-reviewed journal. The goals of this journal are to provide a new avenue for scientists and clinicians to publish their laboratory and clinical research findings, as well as to disseminate information, opinions, and knowledge in cellular and molecular medicine research. Cellular and molecular approaches are pivotal and have long been employed in medicine and clinical research. To cite a few instances, polymerase chain reaction (PCR), a molecular method developed over three decades ago, has been widely applied in disease diagnosis, disease mechanism deciphering, and prognosis prediction; the elucidation of tyrosine kinase activity in cancer cells has led to the development of novel drugs for cancer treatment; and the identification of proteins and genetic molecules by molecular methods as biomarkers for disease diagnosis and prognosis has been drawing great interest. We hope CMMR will serve as a vessel furthering cellular and molecular medicine research. We welcome submissions in the form of original research articles, reviews, short communications, etc. This journal comes into being at the time of an explosion in open access journals. With this recognition, we will make every effort to better meet the needs of authors as well as provide readers with high quality articles. Specifically, during the peer-review process, each submission will be reviewed by experts with relevant expertise, ensuring fair and objective decision-making, which will be guaranteed by experts sitting on the Editorial Board. Additionally, assistance in English editing will be offered to authors whose native language is not English. With hard work and full support from the Editorial Board and the editorial office, I believe the journal will attract submissions from scientists as well as clinicians in the field of cellular and molecular medicine research. I am privileged to have this opportunity to lead the journal and serve our prospective authors and readers, and am looking forward to your contributions and support.\",\"PeriodicalId\":407983,\"journal\":{\"name\":\"Central European Journal of Engineering\",\"volume\":\"106 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central European Journal of Engineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14740/CMMR.V1I1.17\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Journal of Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/CMMR.V1I1.17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
I am greatly honored to be appointed as the inaugural Editor-inChief of Cellular and Molecular Medicine Research (CMMR), an international, open access, and peer-reviewed journal. The goals of this journal are to provide a new avenue for scientists and clinicians to publish their laboratory and clinical research findings, as well as to disseminate information, opinions, and knowledge in cellular and molecular medicine research. Cellular and molecular approaches are pivotal and have long been employed in medicine and clinical research. To cite a few instances, polymerase chain reaction (PCR), a molecular method developed over three decades ago, has been widely applied in disease diagnosis, disease mechanism deciphering, and prognosis prediction; the elucidation of tyrosine kinase activity in cancer cells has led to the development of novel drugs for cancer treatment; and the identification of proteins and genetic molecules by molecular methods as biomarkers for disease diagnosis and prognosis has been drawing great interest. We hope CMMR will serve as a vessel furthering cellular and molecular medicine research. We welcome submissions in the form of original research articles, reviews, short communications, etc. This journal comes into being at the time of an explosion in open access journals. With this recognition, we will make every effort to better meet the needs of authors as well as provide readers with high quality articles. Specifically, during the peer-review process, each submission will be reviewed by experts with relevant expertise, ensuring fair and objective decision-making, which will be guaranteed by experts sitting on the Editorial Board. Additionally, assistance in English editing will be offered to authors whose native language is not English. With hard work and full support from the Editorial Board and the editorial office, I believe the journal will attract submissions from scientists as well as clinicians in the field of cellular and molecular medicine research. I am privileged to have this opportunity to lead the journal and serve our prospective authors and readers, and am looking forward to your contributions and support.